The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
Tetsuya Moritake
Advertisement
Tetsuya Moritake is associate director of Project Leadership & Operations, Pharmaceutical Sciences at Takeda Pharmaceutical.
Articles by Tetsuya Moritake
Advertisement
Latest Updated Articles
Proposing a New Method of Detecting Pinholes in Single-UseSeptember 1st 2020
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide
5